rood blauwe elepsis logo Belegger.nl

Amerikaanse aandelen Terug naar discussie overzicht

Hemispherx BioPharma, Inc (Public, AMEX:HEB)

13.337 Posts
Pagina: «« 1 ... 173 174 175 176 177 ... 667 »» | Laatste | Omlaag ↓
  1. [verwijderd] 7 juni 2009 15:52
    ik heb een vraagje als ik meer aandelen van HEB wil kopen..
    kan ik nu al een order plaatsen? en wanneer koopt ie die aandelen dan pas morgen wanneer de beurs open gaat? misschien is het dan toch al te laat om hem voor 2,73 of 2,75 te kopen ?
  2. veelprocentrendement 7 juni 2009 15:57
    quote:

    kingkong1 schreef:

    De kleur is roodddddddddddddddddddddddddddddddddddddddd
    toen je hem nog had was je o zo positief maar nadat je je ik weet niet hoeveel k winst hebt genomen zit je het alleen maar af te zeiken..

    Last van wissel-stemmingen? Misschien keer vragen of heb daar een medicijn kan tegen ontwikkelen
  3. [verwijderd] 7 juni 2009 15:58
    quote:

    Habeb schreef:

    ik heb een vraagje als ik meer aandelen van HEB wil kopen..
    kan ik nu al een order plaatsen? en wanneer koopt ie die aandelen dan pas morgen wanneer de beurs open gaat? misschien is het dan toch al te laat om hem voor 2,73 of 2,75 te kopen ?
    als u hem nu plaats kan ie pas aangekocht worden vanaf morgen half vier, misschien is het handig toch eerst voorbeurs af te wachten?
    misschien daalt ie nog wel verder.
    en misschien voorbeurs wel afkeuring en dan zit u met de dure aangekochte aandelen... (waar we natuurlijk niet vanuit gaan :-))))
  4. [verwijderd] 7 juni 2009 16:05
    quote:

    JardBiko schreef:

    [quote=kingkong1]
    De kleur is roodddddddddddddddddddddddddddddddddddddddd
    [/quote]

    toen je hem nog had was je o zo positief maar nadat je je ik weet niet hoeveel k winst hebt genomen zit je het alleen maar af te zeiken..

    Last van wissel-stemmingen? Misschien keer vragen of heb daar een medicijn kan tegen ontwikkelen
    volgens mij heeft ie juist compleet de boot gemist bij de stijging en had ie net ervoor alles verkocht hehe, men roept en schreeuwt allemaal maar wat hier merk en lees ik (99%) je kunt niemand geloven hier natuurlijk, vlak voor de klap las ik dat net bijna iedereen verkocht had hahaha, en weer op het dieptepunt teruggekocht, filter enkel de info over HEB uit het draadje, daar hebben we wat aan.
  5. [verwijderd] 7 juni 2009 16:12
    haha ja inderdaad velen maken hier altijd de juiste trades :-)
    en de foute worden natuurlijk gemakkelijkheidshalve per ongeluk even vergeten ;-)
    en al die k's waar er hier mee gestrooid wordt haha...

    nou ik zal zeggen ik heb er niet veel, maar met hetgeen ik heb ben ik superblij ;-)))
    en bij goedkeuring nog meer happy haha
  6. [verwijderd] 7 juni 2009 16:15
    Jin and Juice Investments

    Who knew investing could be so much fun =D
    HEB = STRONG BUY for Monday June 8, 2009

    leave a comment »

    As stated earlier, instead of spending time organizing my thoughts on why HEB is a STRONG BUY for this Monday, June 8, 2009, I will let Lauran Neergaard take the stage:

    “According to a newly published report from Reuters, Japan plans to produce enough H1N1 flu vaccine to treat 20 million people by the end of year, the Yomiuri newspaper reported on Friday. Japan has 410 confirmed cases of the new form of flu, although most have recovered and no patients showed serious symptoms, the health ministry said.

    While most H1N1 flu cases around the world have been mild, the World Health Organization (WHO) has warned countries to get ready for more serious infections if the virus mutates.

    So far, there have been more than 20,000 cases of the new flu around the world and 126 deaths.

    Japanese makers will start producing the vaccine for the new flu strain as early as in early July, with vaccinations available from around November, the newspaper said.

    Health Minister Yoichi Masuzoe said it would take more time for Japan to decide production details for the vaccine doses.

    “The National Institute of Infectious Diseases will probably be able to give makers the seed of a vaccine around June 10,” Masuzoe told reporters when asked about the newspaper report.

    A press release from Hemispherx states that the Japanese National Institute of Infectious Diseases Scientists Identified Hemispherx Biopharma’s Drug Technology as the “Most Promising Mucosal Adjuvant for Influenza

    Interestingly, in his report last Friday, BioMedReport’s M.E. Garza had reported that Hemispherx Biopharma was in deep discussions with the Japanese about selling them Ampligen as an adjuvant (booster) for any vaccine produced for the H1N1 flu.

    Below is an excerpt from that story:

    The same drug used for CFS has now taken center stage in the fight against so called swine flu (H1N1). The company has made headlines in recent days as it has moved full force into collaboration with health ministries and scientists in Japan. In fact, BiomedReports has learned that the company is officially on the fast track to making some substantial sales of its products to Japan. Purchases that will initially treat as many as 30 million Japanese military a

    nd paramedic personnel may be announced soon. When the orders come, research indicates that first year sales figures for Ampligen as a vaccine booster may actually dwarf sales for Ampligen as a treatment for CFS. That trend, as currently projected, will continue for at least the first two years.

    “The highest level of the Japanese government and public medical community is now focused exclusively on our product,” says Carter. “They stopped working on all other adjuvants (boosters) and are only working with this one because they’ve found that it enhances the vaccines by 100 fold.”

    In so called animal (monkey) models, all of the sickest animals’ lives have been saved after researchers added a little Ampligen to the administered novel influenza vaccines. This has all been reviewed by the Japanese National Institutes of Health with great attention since the H1N1 virus has been spreading in that part of the world swiftly and threatens to breakout even further into Asia.

    “Drug safety is the number one priority in Japan,” explains Dr. Carter. “Research there is excellent and their scientists have an outstanding historical safety record.Our research and results are independently verifiable, and internationally recognized.”

    Another tremendous platform in the influenza space is Hemispherx’s flagship product, Alferon which is already approved by the FDA.

    “That’s already passed FDA muster,” says Dr. Carter. “Furthermore, It’s a fully natural interferon- all others are manipulated. That makes it the most effective interferon available. It can stop the SARS coronavirus, Avian Influenza (H5N1) and we have a treatment program with plenty of this drug already stockpiled.”

    In this country, researchers are also looking for ways to deliver a one-two punch to flu viruses, since most antiviral drugs target only half of the cell-infection cycle of viruses such as H1N1. A team of researchers is looking to shut down the whole process according to a report in this week’s Scientific American.

    Flu experts on Friday told the World Health Organization it should provide information on the danger posed by swine flu when it next changes its pandemic alert level.

    WHO Director-General Margaret Chan held an hour-long telephone conference with top scientists from around the world to discuss the latest developments in the outbreak that has infected almost 22,000 people.

    The experts appeared to back a proposal by some of the WHO’s 193 member countries last month to include severity in future assessments. Governments fear that declaring a global pandemic before the full danger of the disease is known could spark panic and confusion, leading to costly and unnecessary actions such as border closures and trade restrictions.

    So far the Geneva-based agency has made the geographic spread of the virus its sole indicator for deciding when to increase the pandemic alert.

    Chan previously consulted the same group before twice raising the alert level last month.

    The disease has meanwhile spread to 69 countries, with the WHO saying that Britain, Spain, Japan, Chile and Australia are moving toward the stage where the flu is passing rapidly from person to person, rather than being brought in by travelers.

    “The committee gave further advice regarding a number of parameters, the monitoring of which will provide information for the assessment of the severity of the epidemic,” WHO said in a statement after the meeting. It did not specify what these parameters would be and WHO officials could not be reached late Friday.

    Hemispherx Biopharma received an invitation, funded entirely by the government of Italy, to present its technology platform for influenza control, yesterday and today at the “International Conference on Biotechnologies and Finance” in Rome’s Sheraton Parco de Medici.”
  7. [verwijderd] 7 juni 2009 16:32
    quote:

    Mr.share schreef:

    Me too. Die oude V12 van Ferrari, wat een geluid was dat.

    wow, hou op haha, dat is nu wel wat minder tegenwoordig pfff.(bromvliegjes)
  8. veelprocentrendement 7 juni 2009 16:32
    quote:

    durfinvest - schreef:

    [quote=JardBiko]
    [quote=kingkong1]
    De kleur is roodddddddddddddddddddddddddddddddddddddddd
    [/quote]

    toen je hem nog had was je o zo positief maar nadat je je ik weet niet hoeveel k winst hebt genomen zit je het alleen maar af te zeiken..

    Last van wissel-stemmingen? Misschien keer vragen of heb daar een medicijn kan tegen ontwikkelen
    [/quote]volgens mij heeft ie juist compleet de boot gemist bij de stijging en had ie net ervoor alles verkocht hehe, men roept en schreeuwt allemaal maar wat hier merk en lees ik (99%) je kunt niemand geloven hier natuurlijk, vlak voor de klap las ik dat net bijna iedereen verkocht had hahaha, en weer op het dieptepunt teruggekocht, filter enkel de info over HEB uit het draadje, daar hebben we wat aan.
    Durf, ik ben het met je eens!

    zo was er iemand die zou 300 k er ingepompt hebben.
    Dat ben je ook wel een kut belegger, want wie gaat er nou 300 k stoppen in een tip die je op het internet leest? bovendien is het nog hartstikke risico vol ook!
  9. [verwijderd] 7 juni 2009 16:36
    quote:

    JardBiko schreef:

    [quote=durfinvest -]
    [quote=JardBiko]
    [quote=kingkong1]
    De kleur is roodddddddddddddddddddddddddddddddddddddddd
    [/quote]

    toen je hem nog had was je o zo positief maar nadat je je ik weet niet hoeveel k winst hebt genomen zit je het alleen maar af te zeiken..

    Last van wissel-stemmingen? Misschien keer vragen of heb daar een medicijn kan tegen ontwikkelen
    [/quote]volgens mij heeft ie juist compleet de boot gemist bij de stijging en had ie net ervoor alles verkocht hehe, men roept en schreeuwt allemaal maar wat hier merk en lees ik (99%) je kunt niemand geloven hier natuurlijk, vlak voor de klap las ik dat net bijna iedereen verkocht had hahaha, en weer op het dieptepunt teruggekocht, filter enkel de info over HEB uit het draadje, daar hebben we wat aan.
    [/quote]

    Durf, ik ben het met je eens!

    zo was er iemand die zou 300 k er ingepompt hebben.
    Dat ben je ook wel een kut belegger, want wie gaat er nou 300 k stoppen in een tip die je op het internet leest? bovendien is het nog hartstikke risico vol ook!
    Zeker, dit forum is zeer goed voor info en tips, je kunt met z,n allen veel meer vinden dan alleen he, maar die aankopen en verkopen moet je echt met een korreltje zout nemen hahaha, iedereen kan alles roepen en schreeuwen wat dat betreft.
  10. [verwijderd] 7 juni 2009 16:41
    quote:

    Antonius86 schreef:

    [quote=Cornelis33]
    Mensen wat had ik een geluk vandaag, had maar liefst 300k stukken hier van 1,12 en heb die verkocht op 4,30! Nu heb ik gelijk weer 300k op 2,40 terug kunnen kopen!
    [/quote]
    Zucht '-_- nog zo'n nieuweling als bij GNBT die alles perfect doet...
    Ja, deze!! echt te grappig...
  11. [verwijderd] 7 juni 2009 16:46
    quote:

    Antonius86 schreef:

    [quote=Antonius86]
    [quote=Cornelis33]
    Mensen wat had ik een geluk vandaag, had maar liefst 300k stukken hier van 1,12 en heb die verkocht op 4,30! Nu heb ik gelijk weer 300k op 2,40 terug kunnen kopen!
    [/quote]
    Zucht '-_- nog zo'n nieuweling als bij GNBT die alles perfect doet...
    [/quote]
    Ja, deze!! echt te grappig...
    ja hahaha die slaat alles ja, maar er waren er nog een boel hoor, moet je maar eens teruglezen toen ie in elkaar klapte naar 2,12 vrijdag, plots had bijna iedereen net verkocht tegen de 4$ "omdat ie zo hard zakte" haha, maar het kan, het kan...
  12. [verwijderd] 7 juni 2009 17:07
    quote:

    kdik23 schreef:

    Jin and Juice Investments

    Who knew investing could be so much fun =D
    HEB = STRONG BUY for Monday June 8, 2009

    leave a comment »

    As stated earlier, instead of spending time organizing my thoughts on why HEB is a STRONG BUY for this Monday, June 8, 2009, I will let Lauran Neergaard take the stage:

    “According to a newly published report from Reuters, Japan plans to produce enough H1N1 flu vaccine to treat 20 million people by the end of year, the Yomiuri newspaper reported on Friday. Japan has 410 confirmed cases of the new form of flu, although most have recovered and no patients showed serious symptoms, the health ministry said.

    While most H1N1 flu cases around the world have been mild, the World Health Organization (WHO) has warned countries to get ready for more serious infections if the virus mutates.

    So far, there have been more than 20,000 cases of the new flu around the world and 126 deaths.

    Japanese makers will start producing the vaccine for the new flu strain as early as in early July, with vaccinations available from around November, the newspaper said.

    Health Minister Yoichi Masuzoe said it would take more time for Japan to decide production details for the vaccine doses.

    “The National Institute of Infectious Diseases will probably be able to give makers the seed of a vaccine around June 10,” Masuzoe told reporters when asked about the newspaper report.

    A press release from Hemispherx states that the Japanese National Institute of Infectious Diseases Scientists Identified Hemispherx Biopharma’s Drug Technology as the “Most Promising Mucosal Adjuvant for Influenza

    Interestingly, in his report last Friday, BioMedReport’s M.E. Garza had reported that Hemispherx Biopharma was in deep discussions with the Japanese about selling them Ampligen as an adjuvant (booster) for any vaccine produced for the H1N1 flu.

    Below is an excerpt from that story:

    The same drug used for CFS has now taken center stage in the fight against so called swine flu (H1N1). The company has made headlines in recent days as it has moved full force into collaboration with health ministries and scientists in Japan. In fact, BiomedReports has learned that the company is officially on the fast track to making some substantial sales of its products to Japan. Purchases that will initially treat as many as 30 million Japanese military a

    nd paramedic personnel may be announced soon. When the orders come, research indicates that first year sales figures for Ampligen as a vaccine booster may actually dwarf sales for Ampligen as a treatment for CFS. That trend, as currently projected, will continue for at least the first two years.

    “The highest level of the Japanese government and public medical community is now focused exclusively on our product,” says Carter. “They stopped working on all other adjuvants (boosters) and are only working with this one because they’ve found that it enhances the vaccines by 100 fold.”

    In so called animal (monkey) models, all of the sickest animals’ lives have been saved after researchers added a little Ampligen to the administered novel influenza vaccines. This has all been reviewed by the Japanese National Institutes of Health with great attention since the H1N1 virus has been spreading in that part of the world swiftly and threatens to breakout even further into Asia.

    “Drug safety is the number one priority in Japan,” explains Dr. Carter. “Research there is excellent and their scientists have an outstanding historical safety record.Our research and results are independently verifiable, and internationally recognized.”

    Another tremendous platform in the influenza space is Hemispherx’s flagship product, Alferon which is already approved by the FDA.

    “That’s already passed FDA muster,” says Dr. Carter. “Furthermore, It’s a fully natural interferon- all others are manipulated. That makes it the most effective interferon available. It can stop the SARS coronavirus, Avian Influenza (H5N1) and we have a treatment program with plenty of this drug already stockpiled.”

    In this country, researchers are also looking for ways to deliver a one-two punch to flu viruses, since most antiviral drugs target only half of the cell-infection cycle of viruses such as H1N1. A team of researchers is looking to shut down the whole process according to a report in this week’s Scientific American.

    Flu experts on Friday told the World Health Organization it should provide information on the danger posed by swine flu when it next changes its pandemic alert level.

    WHO Director-General Margaret Chan held an hour-long telephone conference with top scientists from around the world to discuss the latest developments in the outbreak that has infected almost 22,000 people.

    The experts appeared to back a proposal by some of the WHO’s 193 member countries last month to include severity in future assessments. Governments fear that declaring a global pandemic before the full danger of the disease is known could spark panic and confusion, leading to costly and unnecessary actions such as border closures and trade restrictions.

    So far the Geneva-based agency has made the geographic spread of the virus its sole indicator for deciding when to increase the pandemic alert.

    Chan previously consulted the same group before twice raising the alert level last month.

    The disease has meanwhile spread to 69 countries, with the WHO saying that Britain, Spain, Japan, Chile and Australia are moving toward the stage where the flu is passing rapidly from person to person, rather than being brought in by travelers.

    “The committee gave further advice regarding a number of parameters, the monitoring of which will provide information for the assessment of the severity of the epidemic,” WHO said in a statement after the meeting. It did not specify what these parameters would be and WHO officials could not be reached late Friday.

    Hemispherx Biopharma received an invitation, funded entirely by the government of Italy, to present its technology platform for influenza control, yesterday and today at the “International Conference on Biotechnologies and Finance” in Rome’s Sheraton Parco de Medici.”
    Alleen in het Reuters rapport vind je nergens de naame Hemispherx(HEB) terug...

    de link met HEB wordt enkel en alleen door HEB gelegd.

    versta me niet verkeerd, ik hoop ook op goedkeuring..ik mis alleen wat sterkere bronnen..
  13. [verwijderd] 7 juni 2009 17:15
    Ik heb goede winst gemaakt en heb nabeurs gewoon gekocht.

    Niemand hoeft mij te geloven.

    En de kleur rood was gewoon een grapje.

    Het blijft morgen toch 50/50

    En ik hoop voor iedereen het beste.

    Ook ik sla wel is de plank mis , alleen bij HEB heb ik gewoon heel veel verdiend.

    Ik kan ook voorbeurs en nabeurs handelen.
  14. [verwijderd] 7 juni 2009 17:19
    Vergeet niet er zijun genoeg voorbeelden van bedrijven met goede vooruitzichten en toch een veel te lage koers houden.

    Nogmaals ik gun iedereen veel centjes toe , maar er zijn veel valkuilen op dit moment , en de grote jongens pakken de kleine visjes.

  15. [verwijderd] 7 juni 2009 17:47
    Wij als beleggingsclubje sinds gisteravond hebben de ballen verstand van beleggen. Maar dat mag de pret niet drukken.Wij willen in de zomer naar de Spaanse Costa en hebben nu een pot gemaakt. Met als doel gratis vakantie en vooral gratis drank (heel veel)!!!!!!!
    Hebben jullie nog tips voor ons? Waar moeten we als beginnelingen op letten? Wat zijn de valkuilen?
    Onze dank is nu al groot.
  16. [verwijderd] 7 juni 2009 17:49
    quote:

    geefhetstockjemaardoor schreef:

    Wij als beleggingsclubje sinds gisteravond hebben de ballen verstand van beleggen. Maar dat mag de pret niet drukken.Wij willen in de zomer naar de Spaanse Costa en hebben nu een pot gemaakt. Met als doel gratis vakantie en vooral gratis drank (heel veel)!!!!!!!
    Hebben jullie nog tips voor ons? Waar moeten we als beginnelingen op letten? Wat zijn de valkuilen?
    Onze dank is nu al groot.
    HEBZUCHT ..... altans dat was het in het begin voor mij, de grootste valkuil, daar kun je op de beurs mee ten onder gaan in het begin, steeds meer en meer willen, zelfs bergen met geld gaan lenen om nog maar meer en meer te kunnen winnen hehe, dan kan het fout gaan.
13.337 Posts
Pagina: «« 1 ... 173 174 175 176 177 ... 667 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.930
AB InBev 2 5.394
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.581 50.015
ABO-Group 1 21
Acacia Pharma 9 24.692
Accell Group 151 4.131
Accentis 2 262
Accsys Technologies 22 9.864
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 175
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 13 17.443
Aedifica 3 890
Aegon 3.257 321.809
AFC Ajax 537 7.062
Affimed NV 2 6.111
ageas 5.843 109.854
Agfa-Gevaert 13 1.970
Ahold 3.536 74.174
Air France - KLM 1.024 34.753
AIRBUS 1 10
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.947
Alfen 15 22.729
Allfunds Group 3 1.397
Almunda Professionals (vh Novisource) 651 4.250
Alpha Pro Tech 1 17
Alphabet Inc. 1 384
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.800
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.826 241.396
AMG 967 131.311
AMS 3 73
Amsterdam Commodities 303 6.633
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 419
Antonov 22.632 153.605
Aperam 91 14.616
Apollo Alternative Assets 1 17
Apple 5 358
Arcadis 251 8.682
Arcelor Mittal 2.029 319.964
Archos 1 1
Arcona Property Fund 1 285
arGEN-X 15 9.897
Aroundtown SA 1 215
Arrowhead Research 5 9.552
Ascencio 1 25
ASIT biotech 2 697
ASMI 4.107 38.703
ASML 1.764 94.992
ASR Nederland 19 4.402
ATAI Life Sciences 1 7
Atenor Group 1 386
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 31 12.823
Axsome Therapeutics 1 177
Azelis Group 1 62
Azerion 7 2.939